Report Categories
View AllRecent Articles
View All
Vnda Stock Analysis Vanda Pharmaceuticals Inc. Holds 7 Level After 0.99 Pct Daily Dip 20260403
Biotech Super Bowl Disappoints Stocks Slide Amid Scant Deal Announcements
Moodys Mark Zandi Warns Tariffs Are Slowing Job Growth and Raising Recession Risks
From Partners to Adversaries The MuskAltman AI Rivalry Hits the Courtroom
Jim Cramer on Charles Schwab The Market May Be Misjudging the Brokerage
Trump Seeks Supreme Court Intervention to Halt TikTok Ban
Nuclear Firm Newcleo to List on Nasdaq in 24 Billion Valuation Deal
Bitcoin and Ethereum Decline on Macro Worries and ETF Outflows Amid 400 Million Crypto Liquidation
Lenovo Shares Surge Over 15 on Record Earnings AI Revenue Nearly Doubles
Post Office Horizon Scandal Inquiry Faces FiveYear Delay Without Additional Funding Police Chief Warns
SpaceX IPO Could Rank Among the Largest Stock Market Debuts in History
FNV Q1 2026 Earnings EPS Surpasses Estimates by 137 as Royalty Portfolio Delivers
BC Q1 2026 Earnings EPS Smashes Estimates by 5476 Stock Climbs
Sagimet Biosciences Inc Q1 2026 Earnings Narrowed Loss Beats Expectations as Clinical Pipeline Advances
DSGR Q1 2026 Earnings EPS Exceeds Estimates Despite Stock Decline
Terex Corporation TEX Q1 2026 Earnings EPS Beats Estimates by 25 Amid Solid Execution
CTXR Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss
Cardlytics CDLX Slides as Trading Remains Volatile Near Key Support Levels
Blue Bird Corporation BLBD Slips 181 as Shares Test Key Support Levels
Cornerstone Strategic Investment Fund CLM Posts Modest Gains as Shares Hold Above Key Support
Graham Corporation GHM Rallies 25 Testing Key Resistance at 9971
VGM Advances 126 as Muni Bond Trust Nears Key Resistance at 1078